Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Princess Margaret Cancer Centre, Toronto, ON, Canada


Penelope Bradbury is Staff Medical Oncologist at the Princess Margaret Cancer Centre, Toronto, Canada; Associate Professor, Department of Medicine, University of Toronto, and adjunct Associate Professor within the Department of Oncology at Queen’s University, Kingston, Canada. After obtaining her medical degree from the University of Cardiff, UK, and a fellowship from the Australasian College of Physicians, she undertook postgraduate fellowships at Princess Margaret Cancer Centre and the Canadian Cancer Trials Group, in Ontario, Canada.

She was previously a Senior Investigator in the Canadian Cancer Trials Group for the thoracic and investigational new drugs programme, during which she was Cancer Care Ontario Research Chair in Experimental Therapeutics. Dr Bradbury’s research interests include the evaluation of new therapies for the management of thoracic malignancies and clinical trial methodology. She is the current Chair of the Canadian Cancer Trials Group Thoracic Disease Site Committee.